Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
25,252,463
-
Share change
-
+1,727,172
-
Total reported value
-
$85,093,171
-
Put/Call ratio
-
131%
-
Price per share
-
$3.37
-
Number of holders
-
87
-
Value change
-
+$6,376,368
-
Number of buys
-
37
-
Number of sells
-
35
Institutional Holders of BELLICUM PHARMACEUTICALS INC - COM (BLCM) as of Q1 2019
As of 31 Mar 2019,
BELLICUM PHARMACEUTICALS INC - COM (BLCM) was held by
87 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,252,463 shares.
The largest 10 holders included
JPMORGAN CHASE & CO, BlackRock Inc., BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, ARK Investment Management LLC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., FRAZIER MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, and FMR LLC.
This page lists
87
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.